Publications by authors named "M Schloter"

Atopic dermatitis (AD) is a prevalent inflammatory skin disorder characterized by chronic inflammation, skin barrier dysfunction, and microbial dysbiosis, with playing a significant role in its pathogenesis. This paper explores the strain diversity and microevolution of within AD patients, emphasizing how specific strains adapt to the altered skin environment, exacerbating the condition. The review emphasizes the significance of variation in specific functional genes among strains, which enhances their ability to adapt to different microenvironments and shapes their pathogenic potential.

View Article and Find Full Text PDF

Background: Polymorphic light eruption (PLE) is the most frequent photodermatosis in Europe with an estimated prevalence of 10 to 20%, particularly in temperate climates. Itching or burning lesions appear only in sun-exposed areas, predominantly on the chest, the arms and forearms within a few hours following exposure. The disease's cause is still unknown, yet studies have suggested that skin microbial elements may play a role in its pathogenesis.

View Article and Find Full Text PDF
Article Synopsis
  • - Water temperature significantly affects fish metabolism, and this study focused on how tilapia metabolize the antibiotic florfenicol (FF) at temperatures typical for tropical and subtropical regions.
  • - Tilapia were given a daily dose of 10 mg/kg of FF for 10 days, with tissue samples taken during and after treatment to analyze concentrations of FF and its metabolites using a validated laboratory method.
  • - The findings showed that FF concentration was highest in the kidney, while the primary metabolite, florfenicol alcohol (FFOH), was most prevalent in the liver and fillet, highlighting the efficient absorption and elimination of FF in tilapia raised in warm water.
View Article and Find Full Text PDF

In recent years, microbiomes and their potential applications for human, animal or plant health, food production and environmental management came into the spotlight of major national and international policies and strategies. This has been accompanied by substantial R&D investments in both public and private sectors, with an increasing number of products entering the market. Despite widespread agreement on the potential of microbiomes and their uses across disciplines, stakeholders and countries, there is no consensus on what defines a microbiome application.

View Article and Find Full Text PDF